Evidence map›Paper›PMID 33159622›Full record

ArticleCellular and molecular neurobiology2022

Ischemic Postconditioning Reduces NMDA Receptor Currents Through the Opening of the Mitochondrial Permeability Transition Pore and K

Yudai Morisaki, Ichiro Nakagawa, Yoichi Ogawa, Shohei Yokoyama, Takanori Furuta, Yasuhiko Saito, Hiroyuki Nakase

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Neuroprotective effect of ischemic postconditioning against hyperperfusion and its mechanisms of neuroprotection.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yudai MorisakiDepartment of Neurosurgery, Nara Medical University, Shijocho 840, Kashihara, Japan.ORCID http://orcid.org/0000-0002-6348-2372
Ichiro NakagawaDepartment of Neurosurgery, Nara Medical University, Shijocho 840, Kashihara, Japan. nakagawa@naramed-u.ac.jp.ORCID http://orcid.org/0000-0002-1340-3293
Yoichi OgawaDepartment of Neurophysiology, Nara Medical University, Shijocho 840, Kashihara, Japan.ORCID http://orcid.org/0000-0001-5052-1005
Shohei YokoyamaDepartment of Neurosurgery, Nara Medical University, Shijocho 840, Kashihara, Japan.ORCID http://orcid.org/0000-0002-1849-4200
Takanori FurutaDepartment of Neurosurgery, Nara Medical University, Shijocho 840, Kashihara, Japan.ORCID http://orcid.org/0000-0002-9839-2262
Yasuhiko SaitoDepartment of Neurophysiology, Nara Medical University, Shijocho 840, Kashihara, Japan.ORCID http://orcid.org/0000-0002-0148-6597
Hiroyuki NakaseDepartment of Neurosurgery, Nara Medical University, Shijocho 840, Kashihara, Japan.ORCID http://orcid.org/0000-0002-2726-5960
Nara Medical University · JP

Funding

Kakenhi JP16K10735
6 · The paper itself

Abstract

Ischemic postconditioning (PostC) is known to reduce cerebral ischemia/reperfusion (I/R) injury; however, whether the opening of mitochondrial ATP-dependent potassium (mito-K

Indexed as

Ischemic PostconditioningAdenosine TriphosphateAnimalsMiceMitochondrial Permeability Transition PoreNeuronsReceptors, N-Methyl-D-AspartateAdenosine TriphosphateMitochondrial Permeability Transition PoreReceptors, N-Methyl-D-AspartateCa2+Ischemic postconditioningMitochondrial KATP channelMitochondrial permeability transition poreNMDA receptor

Identifiers

PMID33159622
PMCPMC11441301
OpenAlexW3095586177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.